Why Should Early-Stage Biotechs Care about Intellectual Property?


Hester Sheehan, Research Scientist at Arctoris, reflects on her IP journey on World Intellectual Property Day. April 26th is World Intellectual Property Day and as someone about to embark on a career in this field, I thought this would be a timely opportunity to discuss my thoughts on the importance of intellectual property (IP) for early-stage […]

Early-Stage Drug Discovery and the Importance of High-Quality Data

Goodwin-Arctoris Drug Discovery Masterclass Recap Professionals in drug discovery and development face difficult odds: on average, it takes 12 to 15 years to take a new drug from the idea stage to market approval; that is around one-third of a scientist’s professional life! The costs are eye-watering as well: the price tag of taking a […]